Pay in 4 interest-free payments of $24.20 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
4 nM (hNK-3-CHO binding Ki) Target: NK3 receptorin vitro: In vitro studies demonstrated that 53 is a potent functional antagonist of the hNK-3 receptor (reversal of senktide-induced contractions in rabbit isolated iris sphincter muscles and reversal of NKB-induced Ca2+ mobilization in CHO cells stably expressing the hNK-3 receptor)
2119/molmed
Formula: C12H11NO
In order to examine the role of PKC in p38MAPK phosphorylation
Ivacaftor (benzenesulfonate) Catalog No.:M9558-2 4 nM (hNK-3-CHO binding Ki)VX 770, is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, who account for 45% cases of cystic fibrosis, and is included in a combination drug, lumacaftor ivacaftor, which is used to treat people with cystic fibrosis who have the F508del mutation in CFTR. Ivacaftor is a "potentiator" of CFTR, meaning it increases the probability that the defective channel
US$ 215.50
US$ 120.00
US$ 149.50
US$ 311.00
US$ 116.60
US$ 117.00
US$ 178.00
US$ 185.50
US$ 50.00
US$ 131.00